Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cannabidivarin alleviates α‐synuclein aggregation via DAF ‐16 in Caenorhabditis elegans

30 Dec 2022

Abstract excerpt

Cannabidivarin (CBDV), a structural analog of cannabidiol (CBD), has received attention in recent years owing to its anticonvulsant property and potential for treating autism spectrum disorder. However, the function and mechanism of CBDV involved in the progression of Parkinson's disease (PD) remain unclear. In this work, we found that CBDV inhibited α-synuclein (α-syn) aggregation in an established transgenetic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cannabis and Cannabinoid Research
Share to Genetics, Aging, and Longevity in Model Organisms
Share to Parkinson's Disease Mechanisms and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36583706
DOI: 10.1096/fj.202200278rr

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cannabidivarin alleviates α‐synuclein aggregation via DAF ‐16 in Caenorhabditis elegansPMID 36583706Read ↗

Cannabidiol Recovers Dopaminergic Neuronal Damage Induced by Reserpine or α-synuclein in Caenorhabditis elegansSemantic proximity Read ↗

Found in Translation: The Utility of C. elegans Alpha-Synuclein Models of Parkinson’s DiseaseSemantic proximity Read ↗

Studying the mechanisms of neurodegeneration: C. elegans advantages and opportunitiesSemantic proximity Read ↗

Systematic Review of Caenorhabditis elegans Models for Mechanism Research and Drug Discovery in Parkinson’s DiseaseSemantic proximity Read ↗

Cannabidiol and Trazodone Ameliorate Neuronal Proteotoxicity in C. elegansSemantic proximity Read ↗

Neuroprotective potential of Cannabis sativa-based oils in Caenorhabditis elegansSemantic proximity Read ↗

Nicotine-mediated therapy for Parkinson’s disease in transgenic Caenorhabditis elegans modelSemantic proximity Read ↗

Rosmarinic acid ameliorated oxidative stress, neuronal injuries, and mitochondrial dysfunctions mediated by polyglutamine and ɑ-synuclein in Caenorhabditis elegans modelsSemantic proximity Read ↗

Using a Caenorhabditis elegans Parkinson’s Disease Model to Assess Disease Progression and Therapy EfficiencySemantic proximity Read ↗

Alpha-Synuclein Disrupted Dopamine Homeostasis Leads to Dopaminergic Neuron Degeneration in Caenorhabditis elegansSemantic proximity Read ↗

Dopaminergic neuronal dysfunction induced by newer generation systemic insecticides in <i>Caenorhabditis elegans</i>Semantic proximity Read ↗

Valproic acid ameliorates C. elegans dopaminergic neurodegeneration with implications for ERK-MAPK signalingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.